Pharmacokinetics and Safety Studies of Low Molecular Weight Heparin Nanoconjugates
Low molecular weight heparins (LMWHs) have received widespread acceptance as the first choice for initial prevention and treatment of venous thromboembolism via subcutaneous injection one to two times daily in the clinic. The need for [...]